Stay updated with breaking news from Antiviral Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hyundai Bioscience said Sunday it will develop a broad-spectrum antiviral drug with the U.S. National Institutes of Health (NIH), a federal agency for conducting and supporting medical research.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.
The consortium’s strategy is to create an AI-driven Structure-enabled Antiviral Platform (ASAP), using cutting-edge technology such as advanced structural biology, fragment screening, AI and machine learning, as well as computational chemistry on Folding@home, the world’s largest distributed computing platform to build a robust and open access antiviral discovery pipeline. Click to read more...
Washington: President Joe Biden s medical adviser Anthony Fauci warned that the US should be prepared for pretty bad flu season coupled with continu...
“If we had clinic-ready antivirals suitable for SARS-CoV-2 when the pandemic struck in late 2019, we could have perhaps saved millions of lives,” Ben Perry A bid to discover and develop accessible and affordable oral antivirals to combat outbreaks of COVID-19 and future pandemics has received an initial award of $68 million from the US National Institutes of Health (NIH) that will fund the first three-years of a five-year project to produce preclinical candidates against six viral targets. Click to read more...